Xenon Pharmaceuticals Inc.
XENE· Nasdaq
XENEXenon Pharmaceuticals Inc.
Filed Dec 15, 2014 · 10-Q · 76 days after period end · 0001171843-14-005910
| Metric | Q3 2014 | Q3 2013 |
|---|---|---|
| Revenue | $13.19M | $10.79M |
| Net Income | $9.19M | $6.38M |
| EPS Diluted | $1.69 | $0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Dec 15, 2014 · 76 d after period end
